We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$605M
AUM Growth
-$241M
Cap. Flow
-$219M
Cap. Flow %
-36.12%
Top 10 Hldgs %
39.02%
Holding
350
New
77
Increased
20
Reduced
17
Closed
126
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWCBW
151
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$433K 0.07%
43,749
HLTH
152
DELISTED
Cue Health Inc. Common Stock
HLTH
$421K 0.07%
+203,414
New +$643K
TOACW
153
DELISTED
Talon 1 Acquisition Corp. Warrant
TOACW
$389K 0.06%
37,500
PHYT.WS
154
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$387K 0.06%
37,500
CIIGW
155
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$382K 0.06%
37,500
HCNEW
156
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$374K 0.06%
37,500
ARCKW
157
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
$362K 0.06%
33,333
LENZ
158
LENZ Therapeutics
LENZ
$184M
$359K 0.06%
+16,025
New +$371K
USAS
159
Americas Gold and Silver
USAS
$1.31B
$358K 0.06%
251,760
GTPBW
160
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$355K 0.06%
35,390
SHQAW
161
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$354K 0.06%
35,000
SMRT icon
162
SmartRent
SMRT
$193M
$344K 0.06%
+141,463
New +$350K
OMIC
163
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$341K 0.06%
+5,658
New +$379K
MTVC.WS
164
DELISTED
Motive Capital Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
MTVC.WS
$341K 0.06%
33,333
ACER
165
DELISTED
Acer Therapeutics Inc
ACER
$326K 0.05%
+129,795
New +$223K
ODV
166
DELISTED
Osisko Development Corp
ODV
$318K 0.05%
74,906
OLMA icon
167
Olema Pharmaceuticals
OLMA
$1.01B
$318K 0.05%
+129,631
New +$378K
ASTL icon
168
Algoma Steel
ASTL
$463M
$315K 0.05%
50,000
ONFOW icon
169
Onfolio Holdings Warrant
ONFOW
$82.6K
$304K 0.05%
200,000
HBIO icon
170
Harvard Bioscience
HBIO
$26.7M
$301K 0.05%
+10,876
New +$268K
ONTF
171
DELISTED
ON24
ONTF
$287K 0.05%
+33,225
New +$266K
RVSNW icon
172
Rail Vision Ltd Warrant
RVSNW
$986K
$271K 0.04%
238,265
ROSEW
173
DELISTED
Rose Hill Acquisition Corporation Warrant
ROSEW
$258K 0.04%
24,999
CBRG
174
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
$257K 0.04%
25,000
-75,000
-75% -$762K
BPACW
175
DELISTED
Bullpen Parlay Acquisition Company Warrant
BPACW
$256K 0.04%
25,000

Similar funds

Anson Funds Management's Q4 2022 Portfolio in Review

As of Q4 2022, Anson Funds Management held 350 positions worth $605M, down 28% from $847M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Anson Funds Management withdrew a net $219M in Q4 2022, closing 126 positions and reducing 17 holdings. Its most notable exit was Churchill Capital Corp VII Class A Common Stock, an estimated $35.5M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 8.3% of assets, up from 5.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Anson Funds Management opened a new position in Silvergate Capital Corporation worth $19.4M.

  • Anson Funds Management's largest Q4 2022 buy was Silvergate Capital Corporation: 1,114,704 shares worth $19.4M.
  • Anson Funds Management added most to Tricon Residential Inc. in Q4 2022, an estimated $19.2M increase.
  • Anson Funds Management's biggest Q4 2022 reduction was Shaw Communications Inc., cutting an estimated $26.9M.
  • Anson Funds Management fully exited Churchill Capital Corp VII Class A Common Stock in Q4 2022, selling an estimated $35.5M.
  • Anson Funds Management's ten largest holdings make up 39% of its $605M portfolio in Q4 2022.
  • Anson Funds Management opened 77 new positions and closed 126 in Q4 2022.
  • Anson Funds Management's portfolio value fell 28% quarter-over-quarter to $605M.

Based on Anson Funds Management's 13F filing for Q4 2022, filed 13 Feb 2023.